Company Information

Location

Paris, France

CEO

Gordon Hamilton MD

Website

depixus.com

Social

LinkedIn

Depixus' goal is to commercialise a highly innovative technology platform for the fast, accurate, and inexpensive extraction of genetic and epigenetic information from single molecules of DNA and RNA. The company was initially developed in the laboratory of Vincent Croquette, David Bensimon, and Jean-François Allemand at École Normale Supérieure (ENS), one of France’s leading ‘Grandes Ecoles’.

The company's MAGNATM technology goes beyond decoding the static genetic code to reveal the dynamics of the genome that control health and disease. They analyse single native molecules of DNA, RNA and protein to bring new insights across important emerging areas of biology.